CLINICAL_TRIALS
trial_result
· 2019-03-11
Clinical Trial Update: Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer [NA]
Summary
A completed clinical trial evaluating whether a H2 receptor antagonist can prevent peptic ulcers related to thienopyridine use.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Peptic Ulcer | NA | Status: COMPLETED | Results posted: 2019-03-11